nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiotropium—SLC22A5—dilated cardiomyopathy	0.726	1	CbGaD
Tiotropium—SLC22A5—Furosemide—dilated cardiomyopathy	0.146	1	CbGbCtD
Tiotropium—Prostatic hypertrophy—Furosemide—dilated cardiomyopathy	0.0155	0.179	CcSEcCtD
Tiotropium—Benign prostatic hyperplasia—Furosemide—dilated cardiomyopathy	0.00842	0.097	CcSEcCtD
Tiotropium—Skin infection—Lisinopril—dilated cardiomyopathy	0.00363	0.0418	CcSEcCtD
Tiotropium—Leg pain—Lisinopril—dilated cardiomyopathy	0.00237	0.0274	CcSEcCtD
Tiotropium—Influenza-like symptoms—Lisinopril—dilated cardiomyopathy	0.00153	0.0177	CcSEcCtD
Tiotropium—Laryngitis—Lisinopril—dilated cardiomyopathy	0.00152	0.0175	CcSEcCtD
Tiotropium—Renal failure—Spironolactone—dilated cardiomyopathy	0.00148	0.017	CcSEcCtD
Tiotropium—Herpes zoster—Lisinopril—dilated cardiomyopathy	0.00146	0.0168	CcSEcCtD
Tiotropium—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.0011	0.0126	CcSEcCtD
Tiotropium—Influenza like illness—Lisinopril—dilated cardiomyopathy	0.00106	0.0123	CcSEcCtD
Tiotropium—Urinary retention—Furosemide—dilated cardiomyopathy	0.00101	0.0116	CcSEcCtD
Tiotropium—Dehydration—Furosemide—dilated cardiomyopathy	0.000986	0.0114	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000827	0.00953	CcSEcCtD
Tiotropium—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.000827	0.00953	CcSEcCtD
Tiotropium—Arthritis—Lisinopril—dilated cardiomyopathy	0.000818	0.00943	CcSEcCtD
Tiotropium—Renal failure—Furosemide—dilated cardiomyopathy	0.000803	0.00926	CcSEcCtD
Tiotropium—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.000795	0.00917	CcSEcCtD
Tiotropium—Urticaria—Spironolactone—dilated cardiomyopathy	0.000761	0.00877	CcSEcCtD
Tiotropium—Dehydration—Lisinopril—dilated cardiomyopathy	0.00074	0.00853	CcSEcCtD
Tiotropium—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.000724	0.00835	CcSEcCtD
Tiotropium—Urethral disorder—Furosemide—dilated cardiomyopathy	0.000719	0.00829	CcSEcCtD
Tiotropium—Visual impairment—Furosemide—dilated cardiomyopathy	0.000707	0.00815	CcSEcCtD
Tiotropium—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000706	0.00813	CcSEcCtD
Tiotropium—Eye disorder—Furosemide—dilated cardiomyopathy	0.000685	0.0079	CcSEcCtD
Tiotropium—Pruritus—Spironolactone—dilated cardiomyopathy	0.000678	0.00781	CcSEcCtD
Tiotropium—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.00067	0.00772	CcSEcCtD
Tiotropium—Angiopathy—Furosemide—dilated cardiomyopathy	0.000665	0.00767	CcSEcCtD
Tiotropium—Immune system disorder—Furosemide—dilated cardiomyopathy	0.000662	0.00763	CcSEcCtD
Tiotropium—Arrhythmia—Furosemide—dilated cardiomyopathy	0.000655	0.00755	CcSEcCtD
Tiotropium—Dysuria—Lisinopril—dilated cardiomyopathy	0.000643	0.00741	CcSEcCtD
Tiotropium—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.000639	0.00736	CcSEcCtD
Tiotropium—Malnutrition—Furosemide—dilated cardiomyopathy	0.000638	0.00736	CcSEcCtD
Tiotropium—Dizziness—Spironolactone—dilated cardiomyopathy	0.000633	0.0073	CcSEcCtD
Tiotropium—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00062	0.00715	CcSEcCtD
Tiotropium—Vomiting—Spironolactone—dilated cardiomyopathy	0.000609	0.00702	CcSEcCtD
Tiotropium—Rash—Spironolactone—dilated cardiomyopathy	0.000604	0.00696	CcSEcCtD
Tiotropium—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000603	0.00695	CcSEcCtD
Tiotropium—Renal failure—Lisinopril—dilated cardiomyopathy	0.000603	0.00694	CcSEcCtD
Tiotropium—Vision blurred—Furosemide—dilated cardiomyopathy	0.000602	0.00693	CcSEcCtD
Tiotropium—Headache—Spironolactone—dilated cardiomyopathy	0.0006	0.00691	CcSEcCtD
Tiotropium—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.000596	0.00687	CcSEcCtD
Tiotropium—Epistaxis—Lisinopril—dilated cardiomyopathy	0.000578	0.00666	CcSEcCtD
Tiotropium—Sinusitis—Lisinopril—dilated cardiomyopathy	0.000575	0.00663	CcSEcCtD
Tiotropium—Nausea—Spironolactone—dilated cardiomyopathy	0.000569	0.00656	CcSEcCtD
Tiotropium—Rhinitis—Lisinopril—dilated cardiomyopathy	0.000552	0.00636	CcSEcCtD
Tiotropium—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.000546	0.00629	CcSEcCtD
Tiotropium—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.000543	0.00626	CcSEcCtD
Tiotropium—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.000542	0.00625	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00054	0.00622	CcSEcCtD
Tiotropium—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.000539	0.00622	CcSEcCtD
Tiotropium—Dry mouth—Furosemide—dilated cardiomyopathy	0.000532	0.00613	CcSEcCtD
Tiotropium—Shock—Furosemide—dilated cardiomyopathy	0.000513	0.00591	CcSEcCtD
Tiotropium—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000511	0.00589	CcSEcCtD
Tiotropium—Skin disorder—Furosemide—dilated cardiomyopathy	0.000506	0.00583	CcSEcCtD
Tiotropium—Angiopathy—Lisinopril—dilated cardiomyopathy	0.000499	0.00575	CcSEcCtD
Tiotropium—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.000496	0.00572	CcSEcCtD
Tiotropium—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.000492	0.00567	CcSEcCtD
Tiotropium—Mental disorder—Lisinopril—dilated cardiomyopathy	0.000482	0.00556	CcSEcCtD
Tiotropium—Malnutrition—Lisinopril—dilated cardiomyopathy	0.000479	0.00552	CcSEcCtD
Tiotropium—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000468	0.00539	CcSEcCtD
Tiotropium—Back pain—Lisinopril—dilated cardiomyopathy	0.000463	0.00534	CcSEcCtD
Tiotropium—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000451	0.0052	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00045	0.00518	CcSEcCtD
Tiotropium—Constipation—Furosemide—dilated cardiomyopathy	0.000446	0.00514	CcSEcCtD
Tiotropium—Angioedema—Lisinopril—dilated cardiomyopathy	0.000438	0.00504	CcSEcCtD
Tiotropium—Syncope—Lisinopril—dilated cardiomyopathy	0.00043	0.00495	CcSEcCtD
Tiotropium—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000426	0.00491	CcSEcCtD
Tiotropium—Palpitations—Lisinopril—dilated cardiomyopathy	0.000423	0.00488	CcSEcCtD
Tiotropium—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000421	0.00485	CcSEcCtD
Tiotropium—Cough—Lisinopril—dilated cardiomyopathy	0.000418	0.00482	CcSEcCtD
Tiotropium—Urticaria—Furosemide—dilated cardiomyopathy	0.000414	0.00477	CcSEcCtD
Tiotropium—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000412	0.00475	CcSEcCtD
Tiotropium—Myalgia—Lisinopril—dilated cardiomyopathy	0.000408	0.0047	CcSEcCtD
Tiotropium—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000408	0.0047	CcSEcCtD
Tiotropium—Chest pain—Lisinopril—dilated cardiomyopathy	0.000408	0.0047	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.000405	0.00467	CcSEcCtD
Tiotropium—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000399	0.0046	CcSEcCtD
Tiotropium—Oedema—Lisinopril—dilated cardiomyopathy	0.000391	0.00451	CcSEcCtD
Tiotropium—Infection—Lisinopril—dilated cardiomyopathy	0.000388	0.00448	CcSEcCtD
Tiotropium—Shock—Lisinopril—dilated cardiomyopathy	0.000385	0.00443	CcSEcCtD
Tiotropium—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000384	0.00442	CcSEcCtD
Tiotropium—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000382	0.0044	CcSEcCtD
Tiotropium—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00038	0.00438	CcSEcCtD
Tiotropium—Pruritus—Furosemide—dilated cardiomyopathy	0.000369	0.00425	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000356	0.0041	CcSEcCtD
Tiotropium—Insomnia—Lisinopril—dilated cardiomyopathy	0.000354	0.00408	CcSEcCtD
Tiotropium—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000351	0.00405	CcSEcCtD
Tiotropium—Dizziness—Furosemide—dilated cardiomyopathy	0.000345	0.00397	CcSEcCtD
Tiotropium—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000344	0.00397	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000338	0.00389	CcSEcCtD
Tiotropium—Constipation—Lisinopril—dilated cardiomyopathy	0.000334	0.00385	CcSEcCtD
Tiotropium—Vomiting—Furosemide—dilated cardiomyopathy	0.000331	0.00382	CcSEcCtD
Tiotropium—Rash—Furosemide—dilated cardiomyopathy	0.000329	0.00379	CcSEcCtD
Tiotropium—Dermatitis—Furosemide—dilated cardiomyopathy	0.000328	0.00378	CcSEcCtD
Tiotropium—Headache—Furosemide—dilated cardiomyopathy	0.000326	0.00376	CcSEcCtD
Tiotropium—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00032	0.00368	CcSEcCtD
Tiotropium—Urticaria—Lisinopril—dilated cardiomyopathy	0.000311	0.00358	CcSEcCtD
Tiotropium—Nausea—Furosemide—dilated cardiomyopathy	0.00031	0.00357	CcSEcCtD
Tiotropium—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000309	0.00356	CcSEcCtD
Tiotropium—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000288	0.00332	CcSEcCtD
Tiotropium—Pruritus—Lisinopril—dilated cardiomyopathy	0.000277	0.00319	CcSEcCtD
Tiotropium—Dizziness—Lisinopril—dilated cardiomyopathy	0.000259	0.00298	CcSEcCtD
Tiotropium—Vomiting—Lisinopril—dilated cardiomyopathy	0.000249	0.00286	CcSEcCtD
Tiotropium—Rash—Lisinopril—dilated cardiomyopathy	0.000247	0.00284	CcSEcCtD
Tiotropium—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000246	0.00284	CcSEcCtD
Tiotropium—Headache—Lisinopril—dilated cardiomyopathy	0.000245	0.00282	CcSEcCtD
Tiotropium—Nausea—Lisinopril—dilated cardiomyopathy	0.000232	0.00268	CcSEcCtD
Tiotropium—CHRM2—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.000111	0.00269	CbGpPWpGaD
Tiotropium—CHRM1—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.000111	0.00267	CbGpPWpGaD
Tiotropium—CHRM5—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00011	0.00267	CbGpPWpGaD
Tiotropium—CHRM3—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.00011	0.00266	CbGpPWpGaD
Tiotropium—CHRM2—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.000109	0.00264	CbGpPWpGaD
Tiotropium—CHRM2—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.000107	0.00259	CbGpPWpGaD
Tiotropium—CHRM5—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000107	0.00259	CbGpPWpGaD
Tiotropium—CHRM5—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000107	0.00258	CbGpPWpGaD
Tiotropium—CHRM2—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.000104	0.00251	CbGpPWpGaD
Tiotropium—CHRM2—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.000104	0.00251	CbGpPWpGaD
Tiotropium—CHRM5—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000101	0.00245	CbGpPWpGaD
Tiotropium—CHRM1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	9.77e-05	0.00236	CbGpPWpGaD
Tiotropium—CHRM3—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	9.74e-05	0.00235	CbGpPWpGaD
Tiotropium—CHRM1—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	9.72e-05	0.00235	CbGpPWpGaD
Tiotropium—CHRM5—G alpha (q) signalling events—AGT—dilated cardiomyopathy	9.71e-05	0.00235	CbGpPWpGaD
Tiotropium—CHRM3—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	9.68e-05	0.00234	CbGpPWpGaD
Tiotropium—CHRM2—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	9.66e-05	0.00234	CbGpPWpGaD
Tiotropium—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	9.64e-05	0.00233	CbGpPWpGaD
Tiotropium—CHRM2—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	9.29e-05	0.00225	CbGpPWpGaD
Tiotropium—CHRM5—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	9.14e-05	0.00221	CbGpPWpGaD
Tiotropium—CHRM1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	9.08e-05	0.0022	CbGpPWpGaD
Tiotropium—CHRM3—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	9.05e-05	0.00219	CbGpPWpGaD
Tiotropium—CHRM5—GPCR ligand binding—AGTR2—dilated cardiomyopathy	9.05e-05	0.00219	CbGpPWpGaD
Tiotropium—CHRM5—GPCR ligand binding—CXCL2—dilated cardiomyopathy	9.05e-05	0.00219	CbGpPWpGaD
Tiotropium—CHRM2—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	8.96e-05	0.00217	CbGpPWpGaD
Tiotropium—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	8.79e-05	0.00213	CbGpPWpGaD
Tiotropium—CHRM3—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	8.77e-05	0.00212	CbGpPWpGaD
Tiotropium—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	8.69e-05	0.0021	CbGpPWpGaD
Tiotropium—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	8.68e-05	0.0021	CbGpPWpGaD
Tiotropium—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	8.68e-05	0.0021	CbGpPWpGaD
Tiotropium—CHRM5—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	8.67e-05	0.0021	CbGpPWpGaD
Tiotropium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	8.66e-05	0.00209	CbGpPWpGaD
Tiotropium—CHRM1—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	8.58e-05	0.00208	CbGpPWpGaD
Tiotropium—CHRM3—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	8.55e-05	0.00207	CbGpPWpGaD
Tiotropium—CHRM2—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	8.47e-05	0.00205	CbGpPWpGaD
Tiotropium—CHRM5—GPCR ligand binding—CXCR3—dilated cardiomyopathy	8.41e-05	0.00203	CbGpPWpGaD
Tiotropium—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	8.37e-05	0.00202	CbGpPWpGaD
Tiotropium—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	8.37e-05	0.00202	CbGpPWpGaD
Tiotropium—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	8.34e-05	0.00202	CbGpPWpGaD
Tiotropium—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	8.34e-05	0.00202	CbGpPWpGaD
Tiotropium—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	8.26e-05	0.002	CbGpPWpGaD
Tiotropium—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	8.26e-05	0.002	CbGpPWpGaD
Tiotropium—CHRM5—GPCR ligand binding—ADRB1—dilated cardiomyopathy	8.15e-05	0.00197	CbGpPWpGaD
Tiotropium—CHRM5—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	8.08e-05	0.00195	CbGpPWpGaD
Tiotropium—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	7.78e-05	0.00188	CbGpPWpGaD
Tiotropium—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	7.75e-05	0.00188	CbGpPWpGaD
Tiotropium—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	7.68e-05	0.00186	CbGpPWpGaD
Tiotropium—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	7.53e-05	0.00182	CbGpPWpGaD
Tiotropium—CHRM1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	7.51e-05	0.00182	CbGpPWpGaD
Tiotropium—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	7.51e-05	0.00182	CbGpPWpGaD
Tiotropium—CHRM3—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	7.49e-05	0.00181	CbGpPWpGaD
Tiotropium—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	7.44e-05	0.0018	CbGpPWpGaD
Tiotropium—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	7.41e-05	0.00179	CbGpPWpGaD
Tiotropium—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	7.12e-05	0.00172	CbGpPWpGaD
Tiotropium—CHRM3—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	7.1e-05	0.00172	CbGpPWpGaD
Tiotropium—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	7.03e-05	0.0017	CbGpPWpGaD
Tiotropium—CHRM5—GPCR ligand binding—AGTR1—dilated cardiomyopathy	6.96e-05	0.00168	CbGpPWpGaD
Tiotropium—CHRM1—Circadian rythm related genes—FAS—dilated cardiomyopathy	6.89e-05	0.00167	CbGpPWpGaD
Tiotropium—CHRM1—G alpha (q) signalling events—AGT—dilated cardiomyopathy	6.84e-05	0.00165	CbGpPWpGaD
Tiotropium—CHRM3—G alpha (q) signalling events—AGT—dilated cardiomyopathy	6.81e-05	0.00165	CbGpPWpGaD
Tiotropium—CHRM5—GPCR ligand binding—ADRB2—dilated cardiomyopathy	6.6e-05	0.0016	CbGpPWpGaD
Tiotropium—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	6.43e-05	0.00156	CbGpPWpGaD
Tiotropium—CHRM5—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	6.43e-05	0.00156	CbGpPWpGaD
Tiotropium—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	6.41e-05	0.00155	CbGpPWpGaD
Tiotropium—CHRM1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	6.37e-05	0.00154	CbGpPWpGaD
Tiotropium—CHRM1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	6.37e-05	0.00154	CbGpPWpGaD
Tiotropium—CHRM3—GPCR ligand binding—AGTR2—dilated cardiomyopathy	6.35e-05	0.00154	CbGpPWpGaD
Tiotropium—CHRM3—GPCR ligand binding—CXCL2—dilated cardiomyopathy	6.35e-05	0.00154	CbGpPWpGaD
Tiotropium—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	6.35e-05	0.00154	CbGpPWpGaD
Tiotropium—CHRM2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	6.29e-05	0.00152	CbGpPWpGaD
Tiotropium—CHRM2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	6.29e-05	0.00152	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—ANKRD1—dilated cardiomyopathy	6.15e-05	0.00149	CbGpPWpGaD
Tiotropium—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	6.11e-05	0.00148	CbGpPWpGaD
Tiotropium—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	6.1e-05	0.00148	CbGpPWpGaD
Tiotropium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	6.1e-05	0.00147	CbGpPWpGaD
Tiotropium—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	6.08e-05	0.00147	CbGpPWpGaD
Tiotropium—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	6.03e-05	0.00146	CbGpPWpGaD
Tiotropium—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	6.03e-05	0.00146	CbGpPWpGaD
Tiotropium—CHRM1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	5.92e-05	0.00143	CbGpPWpGaD
Tiotropium—CHRM3—GPCR ligand binding—CXCR3—dilated cardiomyopathy	5.9e-05	0.00143	CbGpPWpGaD
Tiotropium—CHRM2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	5.85e-05	0.00141	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—TAZ—dilated cardiomyopathy	5.78e-05	0.0014	CbGpPWpGaD
Tiotropium—CHRM1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	5.74e-05	0.00139	CbGpPWpGaD
Tiotropium—CHRM3—GPCR ligand binding—ADRB1—dilated cardiomyopathy	5.72e-05	0.00138	CbGpPWpGaD
Tiotropium—CHRM1—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	5.69e-05	0.00138	CbGpPWpGaD
Tiotropium—CHRM3—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	5.67e-05	0.00137	CbGpPWpGaD
Tiotropium—CHRM2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	5.66e-05	0.00137	CbGpPWpGaD
Tiotropium—CHRM2—G alpha (i) signalling events—AGT—dilated cardiomyopathy	5.62e-05	0.00136	CbGpPWpGaD
Tiotropium—CHRM2—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	5.62e-05	0.00136	CbGpPWpGaD
Tiotropium—CHRM5—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	5.54e-05	0.00134	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—SDHA—dilated cardiomyopathy	5.23e-05	0.00127	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	5.11e-05	0.00124	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	5.11e-05	0.00124	CbGpPWpGaD
Tiotropium—CHRM1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	4.9e-05	0.00118	CbGpPWpGaD
Tiotropium—CHRM5—GPCR ligand binding—AGT—dilated cardiomyopathy	4.9e-05	0.00118	CbGpPWpGaD
Tiotropium—CHRM3—GPCR ligand binding—AGTR1—dilated cardiomyopathy	4.88e-05	0.00118	CbGpPWpGaD
Tiotropium—CHRM2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	4.84e-05	0.00117	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	4.75e-05	0.00115	CbGpPWpGaD
Tiotropium—CHRM1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	4.65e-05	0.00112	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—AGTR2—dilated cardiomyopathy	4.64e-05	0.00112	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—CXCL2—dilated cardiomyopathy	4.64e-05	0.00112	CbGpPWpGaD
Tiotropium—CHRM3—GPCR ligand binding—ADRB2—dilated cardiomyopathy	4.63e-05	0.00112	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	4.6e-05	0.00111	CbGpPWpGaD
Tiotropium—CHRM2—GPCR ligand binding—ADRB2—dilated cardiomyopathy	4.59e-05	0.00111	CbGpPWpGaD
Tiotropium—SLC22A4—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	4.53e-05	0.0011	CbGpPWpGaD
Tiotropium—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	4.53e-05	0.00109	CbGpPWpGaD
Tiotropium—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	4.51e-05	0.00109	CbGpPWpGaD
Tiotropium—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	4.47e-05	0.00108	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—CXCR3—dilated cardiomyopathy	4.32e-05	0.00104	CbGpPWpGaD
Tiotropium—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	4.24e-05	0.00103	CbGpPWpGaD
Tiotropium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	4.23e-05	0.00102	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—ADRB1—dilated cardiomyopathy	4.18e-05	0.00101	CbGpPWpGaD
Tiotropium—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	4.13e-05	0.000999	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	3.93e-05	0.000951	CbGpPWpGaD
Tiotropium—CHRM1—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	3.9e-05	0.000944	CbGpPWpGaD
Tiotropium—CHRM3—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	3.89e-05	0.000941	CbGpPWpGaD
Tiotropium—CHRM2—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	3.85e-05	0.000932	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	3.73e-05	0.000902	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	3.68e-05	0.00089	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	3.6e-05	0.000871	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	3.6e-05	0.000871	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	3.59e-05	0.000868	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	3.59e-05	0.000868	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—AGTR1—dilated cardiomyopathy	3.57e-05	0.000864	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	3.55e-05	0.00086	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	3.55e-05	0.00086	CbGpPWpGaD
Tiotropium—CHRM2—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	3.54e-05	0.000855	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	3.46e-05	0.000836	CbGpPWpGaD
Tiotropium—CHRM1—GPCR ligand binding—AGT—dilated cardiomyopathy	3.45e-05	0.000834	CbGpPWpGaD
Tiotropium—CHRM3—GPCR ligand binding—AGT—dilated cardiomyopathy	3.44e-05	0.000831	CbGpPWpGaD
Tiotropium—SLC22A5—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.41e-05	0.000824	CbGpPWpGaD
Tiotropium—CHRM2—GPCR ligand binding—AGT—dilated cardiomyopathy	3.4e-05	0.000823	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—ADRB2—dilated cardiomyopathy	3.39e-05	0.000819	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	3.35e-05	0.00081	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	3.34e-05	0.000807	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	3.3e-05	0.000799	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	3.27e-05	0.000791	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	3.27e-05	0.000791	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—AGTR2—dilated cardiomyopathy	3.26e-05	0.000788	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—CXCL2—dilated cardiomyopathy	3.26e-05	0.000788	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	3.24e-05	0.000784	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	3.23e-05	0.000782	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	3.23e-05	0.000781	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	3.23e-05	0.000781	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	3.2e-05	0.000774	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	3.13e-05	0.000756	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—PSEN2—dilated cardiomyopathy	3.09e-05	0.000747	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	3.04e-05	0.000735	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—CXCR3—dilated cardiomyopathy	3.03e-05	0.000733	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	3e-05	0.000726	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	2.94e-05	0.000712	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—ADRB1—dilated cardiomyopathy	2.93e-05	0.00071	CbGpPWpGaD
Tiotropium—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	2.91e-05	0.000704	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	2.91e-05	0.000703	CbGpPWpGaD
Tiotropium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	2.9e-05	0.000702	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.9e-05	0.0007	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	2.77e-05	0.00067	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.77e-05	0.000669	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	2.76e-05	0.000668	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.74e-05	0.000663	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.74e-05	0.000663	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	2.73e-05	0.000661	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.63e-05	0.000636	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	2.63e-05	0.000635	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	2.62e-05	0.000633	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	2.59e-05	0.000627	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.55e-05	0.000617	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	2.51e-05	0.000608	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—AGT—dilated cardiomyopathy	2.51e-05	0.000608	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—AGTR1—dilated cardiomyopathy	2.51e-05	0.000606	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	2.48e-05	0.0006	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.47e-05	0.000597	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	2.41e-05	0.000582	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	2.39e-05	0.000577	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—ADRB2—dilated cardiomyopathy	2.38e-05	0.000575	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	2.35e-05	0.000569	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	2.26e-05	0.000547	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.18e-05	0.000526	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.17e-05	0.000524	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.15e-05	0.000519	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.11e-05	0.00051	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	2.05e-05	0.000495	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.04e-05	0.000493	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.03e-05	0.000492	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.01e-05	0.000487	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—ADRB2—dilated cardiomyopathy	2e-05	0.000484	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.95e-05	0.000471	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.94e-05	0.00047	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.93e-05	0.000467	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.93e-05	0.000467	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.93e-05	0.000466	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.93e-05	0.000466	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.92e-05	0.000465	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.91e-05	0.000461	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.91e-05	0.000461	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.85e-05	0.000448	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.85e-05	0.000446	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.83e-05	0.000442	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.8e-05	0.000434	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.79e-05	0.000433	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.77e-05	0.000429	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—AGT—dilated cardiomyopathy	1.77e-05	0.000428	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—AGT—dilated cardiomyopathy	1.76e-05	0.000427	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—AGT—dilated cardiomyopathy	1.75e-05	0.000422	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.74e-05	0.000422	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.74e-05	0.000421	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.73e-05	0.000419	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.72e-05	0.000416	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.72e-05	0.000415	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—RAC1—dilated cardiomyopathy	1.55e-05	0.000376	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.49e-05	0.000359	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—AGT—dilated cardiomyopathy	1.48e-05	0.000359	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.48e-05	0.000358	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.47e-05	0.000355	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—GPX1—dilated cardiomyopathy	1.42e-05	0.000344	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.41e-05	0.000341	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.4e-05	0.00034	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.39e-05	0.000336	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—CD36—dilated cardiomyopathy	1.38e-05	0.000335	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—AGT—dilated cardiomyopathy	1.25e-05	0.000301	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.23e-05	0.000297	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.22e-05	0.000296	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.21e-05	0.000293	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.21e-05	0.000293	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.21e-05	0.000292	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.2e-05	0.000289	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.2e-05	0.000289	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—RAC1—dilated cardiomyopathy	1.09e-05	0.000265	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—RAC1—dilated cardiomyopathy	1.09e-05	0.000264	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—RAC1—dilated cardiomyopathy	1.08e-05	0.000261	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—AGT—dilated cardiomyopathy	1.05e-05	0.000253	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—AGT—dilated cardiomyopathy	1.04e-05	0.000252	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—AGT—dilated cardiomyopathy	1.03e-05	0.00025	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—RAF1—dilated cardiomyopathy	1.03e-05	0.000249	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	8.5e-06	0.000205	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.42e-06	0.000204	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.39e-06	0.000203	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.31e-06	0.000201	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	8.28e-06	0.0002	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	7.45e-06	0.00018	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—RAF1—dilated cardiomyopathy	7.25e-06	0.000175	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—RAF1—dilated cardiomyopathy	7.23e-06	0.000175	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—RAF1—dilated cardiomyopathy	7.16e-06	0.000173	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—EGFR—dilated cardiomyopathy	7.07e-06	0.000171	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	5.56e-06	0.000134	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	5.41e-06	0.000131	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—EGFR—dilated cardiomyopathy	4.97e-06	0.00012	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—EGFR—dilated cardiomyopathy	4.96e-06	0.00012	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—EGFR—dilated cardiomyopathy	4.91e-06	0.000119	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	4.87e-06	0.000118	CbGpPWpGaD
